Rectal spacer use and bowel, urinary, and sexual dysfunction diagnosis and related procedures among men receiving prostate radiotherapy: US county-level analysis
Authors:
Open Access
- 7 July 2025
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-8
Abstract
Purpose Clinical studies demonstrate the protective function of rectal spacers to mitigate side effects of radiotherapy (RT) in prostate cancer (PCa) patients. However, large-scale real- world evidence is lacking. This study evaluates the association between rectal spacer use and the prevalence of bowel, urinary, and sexual dysfunction diagnoses and related procedures among PCa patients receiving RT in the US at the county level. Methods Medicare 5% and 100% Standard Analytic Files were used to analyze county-level data from January 2015 to March 2024. The sample included adult PCa patients receiving RT. The primary outcome was the county-level proportion of RT patients diagnosed with bowel, urinary, or sexual dysfunctions or undergoing related procedures. The primary explanatory variable was rectal spacer use 1–5 years before diagnosis. Zero-inflated Poisson regression models were used, controlling for county-level characteristics. Results Among 318,911 PCa patients across 3,168 US counties, the annual prevalence of dysfunction was 2.0% (bowel), 5.6% (urinary), and 1.1% (sexual). Rectal spacer use increased from 4.4 to 18.1% over the study period. A 100-percentage point increase in rectal spacer use at the county level was associated with a 7.1–55.1% reduction in any of three dysfunctions after 1–5 years (all p < 0.05), with similar but weaker trends for related procedures. The strongest association was observed for bowel dysfunction, followed by urinary dysfunction. Conclusion This large-scale, county-level analysis identifies an association between rectal spacer use and lower prevalence of bowel, urinary, and sexual dysfunction, suggesting potential population-level benefits in PCa RT patients.Keywords
Funding Information
- Boston Scientific Corporation
This publication has 24 references indexed in Scilit:
- Prospective, Randomized Controlled Pivotal Trial of Biodegradable Balloon Rectal Spacer for Prostate Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2024
- Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation TherapyJAMA Oncology, 2023
- Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on techniqueWorld Journal of Urology, 2020
- Association of the Placement of a Perirectal Hydrogel Spacer With the Clinical Outcomes of Men Receiving Radiotherapy for Prostate CancerJAMA Network Open, 2020
- Quality of Life After Radiation Therapy for Prostate Cancer With a Hydrogel Spacer: 5-Year ResultsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2017
- Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2017
- Impact of late anorectal dysfunction on quality of life after pelvic radiotherapyInternational Journal of Colorectal Disease, 2012
- Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the ProstateJAMA, 2005
- Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinomaCancer, 1999
- Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991